A Study to Learn About PRT-064040 Nasal Spray in Healthy Adult Subjects

NCT07016516 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

80

Enrollment

INDUSTRY

Sponsor class

Conditions

Migraine

Interventions

DRUG: PRT-064040 nasal spray
DRUG: Placebo
DRUG: PRT-064040 nasal spray
DRUG: Placebo

Sponsor

Sichuan Purity Pharmaceutical Technology Co., Ltd.